Home > Riviste > Minerva Obstetrics and Gynecology > Fascicoli precedenti > Minerva Obstetrics and Gynecology 2022 October;74(5) > Minerva Obstetrics and Gynecology 2022 October;74(5):410-8

ULTIMO FASCICOLO
 

JOURNAL TOOLS

Opzioni di pubblicazione
eTOC
Per abbonarsi
Sottometti un articolo
Segnala alla tua biblioteca
 

ARTICLE TOOLS

Publication history
Estratti
Permessi
Per citare questo articolo
Share

 

ORIGINAL ARTICLE   

Minerva Obstetrics and Gynecology 2022 October;74(5):410-8

DOI: 10.23736/S2724-606X.22.04977-6

Copyright © 2022 EDIZIONI MINERVA MEDICA

lingua: Inglese

Laparoscopic stripping versus endometrioma ethanol sclerotherapy in women with endometrioma awaiting IVF: a long-term analysis of ovarian reserve and pregnancy outcome

Domenico ANTONACI 1, Michele C. SCHIAVI 2, Valerio CARLETTI 2, 3 , Veronica YACOUB 2, 3, Claudia MORGANI 2, 3, Debora GRILLI 2, 3, Francesco GALANTI 1, 3, Azzurra LIGATO 2, 3, Herbert C. VALENSISE 3, 4, Pierluigi PALAZZETTI 2, Rocco RAGO 1

1 Unit of Physiopathology of Reproduction and Andrology, Sandro Pertini Hospital, Rome, Italy; 2 Department of Obstetrics and Gynecology, Sandro Pertini Hospital, Rome, Italy; 3 Department of Obstetrics and Gynecology, Tor Vergata University, Rome, Italy; 4 Department of Obstetrics and Gynecology, Casilino Hospital, Rome, Italy



BACKGROUND: The aim of this study was to compare ovarian reserve, oocytes quality and pregnancy outcome of endometrioma treatment by laparoscopic stripping (LS) versus endometrioma ethanol sclerotherapy (EST) in infertile women awaiting in-vitro fertilization (IVF).
METHODS: Retrospective analysis was performed. Twenty-three women underwent EST and 26 women LS. Intra- and postoperative complications were recorded. The women were followed-up for 36 months for cyst recurrence, oocytes quality and pregnancy outcome. Serum anti-Müllerian hormone (AMH) levels after treatment were measured to observe the impact on the ovarian reserve. Women’s satisfaction was investigated with PGI-I.
RESULTS: During follow-up, there were 3 endometriomas recurrences after LS and none after EST. Six months after treatment AMH was 3.17±2.15 in EST vs. 2.22±1.97 in LS, P=0.045. Symptoms’ improvement was comparable. No intraoperative complications occurred. In the LS group the postoperative complications were significantly higher. After IVF cycles, the quality of the retrieved oocytes was the same. In EST group, clinical pregnancy (48.1% vs. 19.6%) and live birth rates (36.5% vs. 14.3%) were significantly increased compared to LS. Women’s satisfaction was comparable at PGI-I. Both EST and the presence of an endometrioma sized 6 cm or less proved to be independent factors of a better live birth rate in multivariate analysis.
CONCLUSIONS: EST efficacy was greater than LS for endometrioma. Ovarian function was well preserved. Hospital stay was shorter, fewer complications occurred. Pregnancy outcome was better after EST.


KEY WORDS: Endometriosis; Sclerotherapy; Fertilization in vitro

inizio pagina